OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2021
(4)
2023
(2)
2018
(2)
2016
(2)
2014
(2)
2025
(1)
2024
(1)
2022
(1)
2020
(1)
2019
(1)
2015
(1)
2026
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Thoracic combined spinal-epidural anesthesia for laparoscopic cholecystectomy in an obese patient with asthma and multiple drug allergies: a case report.
Not available
S-EPMC6753993
|
biostudies-literature
Cite
Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells.
Not available
S-EPMC10162523
|
biostudies-literature
Cite
Thyromental height test as a new method for prediction of difficult intubation with double lumen tube.
Not available
S-EPMC6136707
|
biostudies-literature
Cite
Effect of high-fidelity simulation on alpha-amylase activity and concentrations of secretory immunoglobulin class A, cortisol, and testosterone among medical students.
Not available
S-EPMC8263411
|
biostudies-literature
Cite
A Type I IFN-Inducing Oncolytic Virus Improves NK Cell-Mediated Killing of Tumor Cells In Vitro Through Multiple Mechanisms.
Not available
S-EPMC12297982
|
biostudies-literature
Cite
Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling.
Not available
S-EPMC8237729
|
biostudies-literature
Cite
Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.
Not available
S-EPMC4301629
|
biostudies-literature
Cite
LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
Not available
S-EPMC4016185
|
biostudies-literature
Cite
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
Not available
S-EPMC8115550
|
biostudies-literature
Cite
PD-L1 blockade enhances anti-tumor efficacy of NK cells.
Not available
S-EPMC6205063
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets